Fund Insights
Common Fund Bets
See what stocks and ETFs funds are collectively bullish/bearish on
Largest Fund Trades
Explore the largest stock and ETF buys and sells made by funds
High Conviction Trades
Discover high conviction trades that caused a significant change in a fund's stake in a stock
Fund Manager Portfolios
Gain insights from the world’s largest funds and super investors
Analyst Insights
Price Target Consensus
See what stocks research analysts are collectively bullish/bearish on
Latest Ratings Feed
Explore the latest ratings and price targets from the best equity research analysts
Equity Analyst Profiles
Browse analysts, their latest ratings and track record
Research Firm Profiles
Browse research firm recommendations, trends, and performance
WSR Indexes
Fund Manager Index
Stock index based on fund manager consensus updated each quarter
Analyst Index
COMING SOON - Stock index based on equity analyst consensus updated every second
Search
Sign in
Sign up
Organon & Co
OGN
Market cap
$2.54B
Overview
Fund Trends
Analyst Outlook
Journalist POV
9.76
USD
+0.43
4.61%
At close
Updated
Apr 17, 4:00 PM EDT
Pre-market
After hours
9.76
0.00
0%
1D
5D
1M
3M
6M
YTD
1Y
5Y
10Y
1 day
4.61%
5 days
13.89%
1 month
52.74%
3 months
3.17%
6 months
5.17%
Year to date
34.81%
1 year
-12.23%
5 years
-70.65%
10 years
-70.65%
Upgrade to unlock
Positive
Neutral
Negative
Sentiment
3-Months
Positive
Neutral
40%
Negative
Positive
Neutral
Negative
Neutral
Zacks Investment Research
22 hours ago
Organon (OGN) Rises Higher Than Market: Key Facts
The latest trading day saw Organon (OGN) settling at $9.33, representing a +1.3% change from its previous close.
Neutral
Business Wire
yesterday
Organon To Report First Quarter 2026 Results and Host Conference Call on May 7, 2026
JERSEY CITY, N.J.--(BUSINESS WIRE)--Organon will release its first quarter 2026 financial results and host conference call on May 7, 2026.
Neutral
Business Wire
2 days ago
Organon's VTAMA® (tapinarof) cream, 1%, Granted Strong Recommendation in the 2026 American Academy of Dermatology Guidelines for Pediatric Atopic Dermatitis
JERSEY CITY, N.J.--(BUSINESS WIRE)--VTAMA was the only steroid-free topical AAD found supported by high certainty of evidence across all severities in children 2 years and older with AD.
Neutral
Zacks Investment Research
3 days ago
Organon (OGN) Stock Drops Despite Market Gains: Important Facts to Note
In the latest trading session, Organon (OGN) closed at $8.54, marking a -3.28% move from the previous day.
Positive
Benzinga
7 days ago
Sun Pharma Nears Final Offer For Organon In Largest Overseas Bet
Citing people familiar with the matter, the Economic Times reported that Sun Pharma has completed an extensive due diligence process spanning more than three months.
Positive
Zacks Investment Research
7 days ago
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know
Organon (OGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Positive
Barrons
7 days ago
This Women's Health Company Is Drawing Takeover Interest. The Stock Is Soaring.
Organon stock jumped after a report said Sun Pharmaceutical Industries is nearing an all-cash deal for the women's health company.
Positive
Investopedia
7 days ago
This Women's Healthcare Stock Is Up 15% on Reports of a Takeover In the Works
Organon shares are popping Friday on signs of a takeover deal.
Positive
Barrons
7 days ago
These Stocks Are Today's Movers: Nvidia, Intel, Lumentum, Coherent, Organon, and More.
Lumentum and Coherent were gaining on signs of strong artificial-intelligence hardware demand, while Organon was boosted by a takeover report.
Negative
Zacks Investment Research
10 days ago
Organon (OGN) Stock Sinks As Market Gains: Here's Why
In the most recent trading session, Organon (OGN) closed at $6.05, indicating a -4.87% shift from the previous trading day.
Show more
See News Rankings
Sign up
Sign in
Fund Insights
Common Fund Bets
See what stocks and ETFs funds are collectively bullish/bearish on
Largest Fund Trades
Explore the largest stock and ETF buys and sells made by funds
High Conviction Trades
Discover high conviction trades that caused a significant change in a fund's stake in a stock
Fund Manager Portfolios
Gain insights from the world’s largest funds and super investors
Analyst Insights
Price Target Consensus
See what stocks research analysts are collectively bullish/bearish on
Latest Ratings Feed
Explore the latest ratings and price targets from the best equity research analysts
Equity Analyst Profiles
Browse analysts, their latest ratings and track record
Research Firm Profiles
Browse research firm recommendations, trends, and performance
WSR Indexes
Fund Manager Index
Stock index based on fund manager consensus updated each quarter
Analyst Index
COMING SOON - Stock index based on equity analyst consensus updated every second
Theme
Close